Gunderson Dettmer has advised Andersen Group Inc. Latham & Watkins has advised the underwriters. Whalen LLP has represented the selling stockholders. Andersen Group Inc. (NYSE: ANDG),...
Andersen Group Secondary Share Offering Raises $188.5 Million
Hims & Hers Completes Upsized $402.5 Million Convertible Senior Notes Offering
Gunderson Dettmer has advised Hims & Hers. Hims & Hers (NYSE: HIMS) has completed an upsized offering of $402.5 million aggregate principal amount of 0.00% convertible...
Hims & Hers to Acquire Eucalyptus in USD1.15 Billion Transaction
G+T and Cooley have advised Eucalyptus. Gunderson Dettmer and Osborne Clarke have advised Hims & Hers Health, Inc. K&L Gates has advised Blackbird Ventures. Australian digital...
Andersen Group Launches $176 Million Initial Public Offering
Gunderson Dettmer has advised Andersen Group Inc. Cooley LLP has represented the underwriters. Andersen Group Inc. (NYSE: ANDG), a provider of independent tax, valuation, and financial...
Hims & Hers Announces Acquisition of YourBio Health
Gunderson Dettmer has advised Hims & Hers. Hims & Hers Health, Inc. (NYSE: HIMS) has entered into a definitive agreement to acquire YourBio Health, Inc., a...
Hims & Hers Acquires Canadian Digital Health Platform Livewell
Gunderson Dettmer has advised Hims & Hers. Hims & Hers (NYSE: HIMS), a leading health and wellness platform, has completed the acquisition of Livewell, a Canadian...
BillionToOne Completes $273.1 Million Initial Public Offering
Gunderson Dettmer has advised BillionToOne, and Cooley has represented the underwriters. BillionToOne, Inc., a molecular diagnostics company, has completed an upsized initial public offering, raising approximately...
Aeva Technologies Completes US$100 Million Convertible Senior Notes Placement
Gunderson Dettmer has advised Aeva Technologies, and White & Case LLP has advised Apollo-managed funds. Apollo-managed funds have completed a US$100 million private placement of 4.375%...
Arcus Biosciences Completes $287.5 Million Common Stock Offering
Latham & Watkins has advised Arcus Biosciences. Gunderson Dettmer has advised the underwriters. Arcus Biosciences, a clinical-stage, global biopharmaceutical company listed on the NYSE under the...
GRAIL Announces $325 Million Private Placement
Gunderson Dettmer has advised Hims & Hers. Latham & Watkins has advised GRAIL, Inc. GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
Hims & Hers to Acquire ZAVA
Gunderson Dettmer and Taylor Wessing advised Hims & Hers on the transaction. Hims & Hers, a leading health and wellness platform (NYSE: HIMS) has entered into...
Hims & Hers to Acquire ZAVA
Gunderson Dettmer has advised Hims & Hers on the transaction. Hims & Hers, a leading health and wellness platform (NYSE: HIMS) has entered into a definitive...